Journal of the American Pharmaceutical Association (Washington, D.C. : 1996) · 1999
New drugs of 1998.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hussar D A
Аннотация
OBJECTIVE: To provide information regarding the most important properties of the new therapeutic agents marketed in 1998.
DATA SOURCES: Published studies, drug information reference sources, and product labeling.
DATA SYNTHESIS: In 1998, 44 new therapeutic agents were marketed. The indications and information on dosage and administration for each new agent are reviewed, as are the most important pharmacokinetic properties, adverse events, drug interactions, and other precautions. Practical considerations for the use of the new agents are also discussed. Where possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications.
CONCLUSION: A number of the new therapeutic agents marketed in 1998 have important advantages over older medications. An understanding of the properties of these agents is important for the pharmacist to effectively counsel patients about their use and to serve as a valuable source of information for other health professionals regarding these drugs.
DATA SOURCES: Published studies, drug information reference sources, and product labeling.
DATA SYNTHESIS: In 1998, 44 new therapeutic agents were marketed. The indications and information on dosage and administration for each new agent are reviewed, as are the most important pharmacokinetic properties, adverse events, drug interactions, and other precautions. Practical considerations for the use of the new agents are also discussed. Where possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications.
CONCLUSION: A number of the new therapeutic agents marketed in 1998 have important advantages over older medications. An understanding of the properties of these agents is important for the pharmacist to effectively counsel patients about their use and to serve as a valuable source of information for other health professionals regarding these drugs.